Site is Being Upgraded

A probiotic-based immune enhancement therapy: Probiotic Lactobacillus reuteri increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene, 6/December/2018, 10.47 pm

A sweet way to treat Metastatic cancers: Xylobiose, a disaccharide of xylose, increases the expression of tumor/metastatic suppressors LATS1 and SMARCD4, inhibits cell cycle progression, and suppresses migration, invasion and metastasis of cancer cells via up-regulation of its target gene, 6/December/2018, 10.38 pm
December 6, 2018
A probiotic way to say no to weight gain and Diabetes: Probiotic-based therapy for body weight control, energy homeostasis and TIIDM: Probiotic Bifidobacterium pseudocatenulatum  decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 7/December/2018, 10.22 pm
December 7, 2018
Show all

Introduction: What they say:  

A recent study from the Institute of Biophysics, Chinese Academy of Sciences, Beijing, China shows that “Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate immunity against microbial infection.” This study was published, in the 2 March 2015 issue of the Journal “Nature Immunology” [the number one journal in immunological research with an impact factor of  24.973], by Drs. Zusen Fan, Xia and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, the Director-cum-chief Scientist of GBMD, reports that: A probiotic-based immune enhancement therapy: Probiotic Lactobacillus Brevis increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene


From Research Findings to Therapeutic Opportunity:

This study suggests, for the first time, Lactobacillus reuteriby decreasing the expression of its target gene, it may : (1) increase the expression of Sox2; (2) increase the ability of Sox2 to recognize bacterial DNA in the cytoplasm; and (3) promote innate immunity against bacterial infection. 

Figure 1. Probiotic-based immune enhancement therapy. Probiotic Lactobacillus reuteri, by increasing the expression of its target genes, it increases the expression of Sox-2 and its downstream components in the signaling pathway. And, thereby, promotes anit-bacterial immunity.

Figure 2. Probiotic Lactobacillus reuteri may increase resistance against bacterial infection through induction of Sox2

Together, pharmacological formulations encompassing “Lactobacillus reuteri,  either alone or in combination with other drugs,” may be used to (1) enhance innate immunity against bacterial infection; and (2) promote bacterial resistance (figs. 1-2). 


Details of the research findings

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information:

How Lactobacillus reuteri(1) enhances innate immunity against bacterial infection; and (2) promotes bacterial resistance?

Amount: $750

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L., A probiotic-based immune enhancement therapy: Probiotic Lactobacillus reuteri increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene, 6/December/2018, 10.47 pm,  Genome-2-BioMedicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.